Diversification of microfluidic technologies has led to burgeoning new applications and market growth, driving players’ interest and M&A.
More information on https://www.i-micronews.com/products/status-of-the-microfluidics-industry-2019/
4. 4
Glossary and definitions p.2
Table of contents p.3
Report objectives p.5
Report scope p.6
Report methodology p.7
About the authors p.8
Companies cited in this report p.9
What we got right, What we got wrong p.10
Who should be interested by this report p.11
Yole Group related reports p.12
Executive Summary p.15
Context p.52
o Definition – our vision of microfluidics
o Microfluidics – advantages and drawbacks
o Our vision of the microfluidics market
o Examples of applications that use microfluidic products
o Why are microfluidic solutions used?
o Microfluidic applications – definitions
Market forecasts p.62
o Market segmentation
o Market forecasts for microfluidic products and devices (units and value)
o Segment dynamics (CAGR vs. Segment size)
o How the value is spread across the supply chain
o What we got right/wrong and why
o Material mix analysis
o Conclusion
TABLE OF CONTENTS
Part 1/2
Market trends p.87
o An increasing on-chip complexity for ever more integration and automation
o Razor and razor-blade business model
o A myriad of microfluidic players
o In-house vs. Outsourced production
o The lure of high-volume microfluidic device production
o Reaching commercial success is not an easy path
o Addressing other markets before human diagnostics, a wrong good idea?
o Road to market: comparison of applications
o Distribution networks are key for success
o Examples of distribution agreements
o A limited market for the fabs
o Is the key to success out of point-of-care?
o The market growth paradox!
o Reasons why companies choose to internalize production
o The barriers of in-house production
o Why don’t large companies work (much) with the fabs?
o A fight to acquire value
o Significant new entrants
o Towards standardized cartridge footprints?
o Having a fixed design and a secured supply chain is mandatory
o Combining the development of instrument and consumable
o Importance of multiplexing and wide assay menu
o The development of « open platform » business models
o Standardization of microfluidic devices: setting-up an ISO norm
o Success of Microfluidic technologies - Dream or reality?
o Financial analysis of publicly listed companies
5. 5
TABLE OF CONTENTS
Part 2/2
Microfluidic segments description p.139
o Clinical and veterinary testing
o Point-of-care testing
o Industrial, environmental, and agro-food testing
o Pharmaceutical and life science research
o Micro-reaction and flow chemistry
o Analytical devices
o Drug delivery
o Accurate dispensing
o Flow control components and modules
o Emerging applications
Focus: Microfluidic technologies for biotech applications p.203
o Overview
o Single-cell isolation and analysis
o Cell line development
o Gene editing and therapeutics
o Supply chain and business models
Market shares & supply chain p.266
o Different models for different volumes
o Microfluidic integrators, per material
o Microfluidic integrators: 2018 market share
o Main mergers and acquisitions since 2017 + analysis
o Fundraising since 2017 + analysis
o Microfluidic fabs: overview, geographical location, materials, ranking
o Other levels of the supply chain (design houses, prototyping houses,
materials providers, etc.)
o Analysis of recent acquisitions of microfluidic fabs
o Who’s working with who?
Technology trends p.341
o Materials & hybrid integration
o Manufacturing processes comparison
o Reshaping processes
o Subtractive processes
o 3D printing
o Combination of manufacturing expertise
o Cost analysis: cost of goods, yield, split across the manufacturing process,
contribution of the device in the final product selling price, gross margin
analysis
o Detection methods + focus on acoustic detection methods
o Integration of complex sample prep steps
o Multiplexing: high-plex vs. low-plex
o Smartphone-based diagnostic products
o Mixing technologies
Outlooks p.374
o Conclusions
Yole Corporate Presentation p.380
6. 6
This new Yole Développement report provides a complete analysis of microfluidic device/product applications,
markets, and technologies:
o New major trends and evolutions in the microfluidics industry markets and business models
o Analysis of strategic moves since 2017: mergers and acquisitions, fundraising, etc.
o New microfluidic players/foundries - 2018 rankings
o Updated market data and forecast up to 2024, in value and units for microfluidic devices and products
o Supply chain description and analysis
In order to better understand how value is distributed across the supply chain, this report covers both the
microfluidic device and microfluidic-based product markets
Market trends and main players are presented for each product category via an exclusive market segmentation
An exhaustive analysis is supplied covering the materials and manufacturing processes in various microfluidic
segments
Also furnished is a presentation of new, promising applications for microfluidic technologies
REPORT OBJECTIVES
7. 7
REPORT SCOPE
Yours needs are
out of the report’
scope?
Contact us for a custom:
Other methods controlling
very small fluid volumes
Microfluidics is the science and technology that deals with the manipulation of fluids, usually in
the range of microliters (10-6) to picoliters (10-12) and/or in networks of micrometer-size
channels
Our definition of microfluidics encompasses:
Micro-fabricated devices with
channels below ~500µm in size
and/or
8. 8
METHODOLOGIES & DEFINITIONS
Market
Volume (in Munits)
ASP (in $)
Revenue (in $M)
Yole’s market forecast model is based on the matching of several sources:
Information
Aggregation
Preexisting
information
9. 9
WHO SHOULD BE INTERESTED IN THIS REPORT?
Financial & strategic investors:
o Realize microfluidic technologies’ potential
o See the latest moves within the industry
o Learn the sweet spots and growing applications, and
understand end-users’ objectives
R&D players:
o Understand new challenges linked to microfluidic
technologies
o Address the right market with the right technology
Healthcare & governmental organizations:
o Evaluate microfluidic technologies’ benefits
o Identify relevant companies
Diagnostics, pharmaceutical, biotechnology, industrial,
and other companies:
o Understand what is “state of the art” in microfluidic
technologies, and which solutions could bring
operational benefits
o Identify the different players across the supply chain
o Comprehend behavior evolution
o Highlight competitors and targets for collaborations
or M&A
Microfluidic foundries and device makers:
o Grasp technical requirements
o Recognize business opportunities and prospects
o Understand the evolution of the supply chain
MEMS, electronics, and optics players:
o Perceive the microfluidics market and technologies
o Interpret the requirements for market entry
11. 11
Microfluidic
Applications
MICROFLUIDIC APPLICATIONS - DEFINITION
Microfluidic
technology is
used
everywhere
Clinical &
Veterinary
Diagnostics
Point-of-
Care
Diagnostics
Pharma &
Life Science
Research
Analytical
Devices
Industrial,
Environmental
& Agro-Food
Drug
Delivery
Micro
Reaction -
Flow
Chemistry
• Clinical and Veterinary Diagnostics
Laboratory equipment for clinical and veterinary
diagnostics
• Point-of-Care Diagnostics
Diagnostic equipment for out-of-reference laboratory, near-
patient testing (intensive care, doctor’s offices, home
testing, etc.)
• Pharmaceutical and Life Science Research
Microfluidic devices for drug discovery and screening,
genomics, proteomics, cell analysis
• Analytical Devices
Microfluidic chips and columns for mass spectrometry,
chromatography, and HPLC sample preparation
• Industrial, Environmental, and Agro-FoodTesting
Microfluidic-based tests for quality/process control and
food/water testing (pesticides, bacteria, etc.). Includes
military, security, and forensics applications.
• Drug delivery
Microfluidic devices for drug delivery, such as inhalers,
microneedles, and implantable micropumps
• Micro Reaction - Flow Chemistry
Microfluidic devices for micro reaction involved in research
or in pilot-production units
12. 12
INTRODUCTION
Microfluidics - advantages and drawbacks
Reduced sample and reagent volumes
Shorter times for liquid displacement,
thermal transfers, and analysis
Automation and integration of complex
operations Precise liquid control
Diffusion-based mixing (due to
highly-viscous forces) takes time
Actuation is required for improving mixing steps
Better control of chemical reactions Improved safety for chemical reactions
13. 13
INTRODUCTION
Our vision of the microfluidics market (1/3)
Example: Binx Health
analyzer
Microfluidic device: chip
(raw hardware)
Microfluidic product: cartridge with
reagents and packaging
Example: Binx Health
cartridge
Microfluidic analyzer
14. 14
We divided microfluidic technologies into two types of components in order to better explain the microfluidics
market:
o Microfluidic device:
• A microfluidic device is defined as a micro-structured component in which a fluid will flow when it
will be used. This can be a chip, a dispensing tool, a flow control component, or other microfluidic
component types. It a the first-level packaged component.
• Microfluidic chips represent 85% (in value) of the microfluidic device market.
o Microfluidic product:
• A microfluidic product is defined as the microfluidic device packaged for sale to the end-user
• When needed, reagents and biological content are added to the device to create the product. It can
be surface functionalization with antibodies or nucleic acid probes, liquid buffers in blisters, deposition
of dry reagents, etc.
• For example, in point-of-care applications, the microfluidic product is a microfluidic device to which reagents
are added. The functionalized chip is packaged into a cartridge (often in plastic) with all the other required
elements.
• Complex cartridges can sometimes integrate tens or even hundreds of elements!
We also consider microfluidic instruments for detection (diagnostics: chip readers), for droplet generation, for
flow/pressure control, for dispensing, etc. However, these instruments are not quantified (either in volume nor in
value) in this report.
INTRODUCTION
Our vision of the microfluidics market (2/3)
15. 15
INTRODUCTION
Our vision of the microfluidics market (3/3)
Most
microfluidic
devices are chips.
When combined
with biological
content and
packaged into
cartridges, these
chips become
products.
Chips
Other
Devices
Microfluidic product breakdown for
chips and other devices in 2018, in $B
Chips
$2.6B
Other
$0.4B
Devices
$3.0B
Products
$8.8B
24. 24
Contact our
SalesTeam
for more
information
Chinese Microfluidics
Industry 2018
Point-of-Need Testing:
Application of Microfluidic
Technologies
Next-Generation Sequencing
& DNA Synthesis 2019
Liquid Biopsy: From Isolation to
Downstream Applications 2018
YOLE GROUP RELATED REPORTS
Yole Développement
27. The first commercially-available lab-on-a-
chip devices are now more than 20 years old.
Microfluidic device complexity has increased
ever since, leading to extremely sophisticated
cartridges performing automated, complex
sample preparation steps. Microfluidics is now
a mature technology, and today the identified
number of companies developing microfluidic-
based solutions worldwide far surpasses a
thousand (including myriad opportunistic start-
ups), and the applications are end-less. As a
consequence, Yole Développement’s (Yole)
analysts estimate that the microfluidic products
market reached $8.7B in 2018, and will grow at a
CAGR2019-2024
of 11.7%, reaching $17.4B. The two
principal applications are still point-of-care (PoC)
testing and pharmaceutical/ life science research
(including sequencing, genomics, and proteomics).
However, the dynamics per application are
evolving. While PoC devices are increasing in
complexity and integrating more and more hybrid
materials (i.e. glass + polymer, or silicon + polymer
in order to offer additional functions), we also see
high-end applications increasingly using polymer
when possible, in order to decrease costs. Glass
and silicon have a large share in these applications,
especially in sequencing, but these semiconductor
materials are increasingly integrated at the heart
of complex plastic cartridges. This is also the
case in drug delivery – even though most devices
are made of glass and silicon today, we may soon
observe the entry of polymer devices. Overall,
thanks to increased commercial adoption, all
three materials are growing nicely. In this report,
Yole’s analysts present 2017 – 2024 market data
and forecasts per application, with a detailed
material mix analysis.
STATUS OF THE MICROFLUIDICS INDUSTRY 2019
Market & Technology Report - August 2019
MICROFLUIDICS APPLICATIONS ARE GREATLY DIVERSIFYING, CREATING
NEW OPPORTUNITIES
Diversification of microfluidic technologies has led to burgeoning new applications and market growth,
driving players’ interest and M&A.
Global microfluidic devices and products market: 2019-2024 forecast
WHAT’S NEW
• Updated 2017 - 2024 market data
and forecasts (in $US and units) for
microfluidic devices and products,
along with material mix analysis
• Evolution and estimated 2018
microfluidic players’ market share at
fab level and end-product level
• Breakdown of the latest industry
moves (M&A, fundraising), market
and technology trends and evolutions,
and potential acquisition targets
• Updated information, by microfluidic
market segment
• Review of new, promising applications
for microfluidic technologies
(including a focus on biotechnology
applications)
• Comprehensive supply chain analysis
KEY FEATURES
• Provide a global view of the future for
microfluidic devices and products
• Establish an understanding of
every microfluidics application, with
an overview of the main players per
application
• Analyze microfluidic players’ dynamics
and ranking, and understand
the latest industry trends,
strategic moves, and business models’
evolutions
• Furnish 2017 and 2018 market data
for microfluidic products and devices,
along with 2019 – 2024 forecasts in
units and $US
• Explore technology, materials, and
manufacturing trends
• Explain how the supply chain
is organized and how value is
distributed across it
THE ACQUISITION WAVE CONTINUES, LEADING TO AN IMPRESSIVELY
RAPID STRUCTURATION
For the last decade, PoC has been considered
microfluidics’ greatest promise, with the potential
for rapid-testing cartridges to reach millions of
units per year.Nonetheless,the mass production of
such devices is still far from being widespread, and
companies now realize that the barriers are high on
the road to success.Just having a good technology is
not enough: financial strength, supply chain security,
regulatory, and market access are also mandatory.
In particular, numerous companies struggle to
reach the next step because of a weak commercial
network. Thus, acquisition by a larger company is
often a good way to gain access to an established
distributionnetworkandimprovedlogisticssupport.
BioFire (bioMérieux), IQuum (Roche), and Cepheid
(Danaher) are good examples of technologies
that have literally taken off after acquisition, and
we will see in the coming years whether recently-
acquired companies like GenePOC (Meridian
Biosciences) and Abaxis (Zoetis) mimic these
successes. Overall, large diagnostic companies
have acquired numerous promising or successful
microfluidic technologies through the purchase of
small and medium-size companies, to the extent
that a group of around 15 players now represents
more than 75% of the market.This is an impressive
concentration, especially given the variety of
applications. Contrarily, hundreds of start-ups with
low revenue struggle to reach commercial success
for the reasons mentioned above. In-between,
we find around 50 players with $10M – 100M
in microfluidics revenue, mostly start-ups that
have accessed the next steps and are now likely
acquisition targets.
(Yole Développement,August 2019)
28. STATUS OF THE MICROFLUIDICS INDUSTRY 2019
At another supply chain level, we observe an
impressive structuration. Indeed, the microfluidic
device manufacturers (“fabs”) have experienced a
strong wave of acquisitions by larger players since
2015 – the latest being MiniFAB in June 2019. Such
larger players thus acquire their own production
facilities and aim to produce for larger customers
from the diagnostics and life sciences fields,
which fabs today struggle to address. Overall,
after the recent acquisitions, the only remaining
established microfluidic fabs above $10M in
revenue and still independent are Micronit and
Microfluidic ChipShop. Last but not least, over the
past two years several large companies (leaders
in other technology fields) have decided to enter
or strengthen their position in the microfluidics
market: this is the case for Technicolor, Qorvo
Biotechnologies, and Schott. Such decisions
exemplify the attractiveness of this dynamic field,
which presents a viable opportunity for these
companies to find new growth areas. They will
soon be followed by others – in fact, we are
aware of several players that are preparing to
enter the microfluidics field, at diverse levels of
the supply chain!
MICROFLUIDIC TECHNOLOGIES ARE PENETRATING VARIOUS FLOURISHING
APPLICATIONS, WHERE THE CHALLENGES ARE BIG BUT THE POTENTIAL IS
SIGNIFICANT
Emerging applications, in particular within
the biotechnology field, can benefit from the
improvement of microfluidic technologies which
represent valuable tools for complex operations.
Today, academics and researchers are the main
users of such technologies in biotech, but we
have begun seeing an increased adoption from
pharmaceutical companies, Contract Research
Organizations (CRO), and industrial biotech
companies: for example, cell line development,
single-cell isolation/analysis, as well as cell-gene
therapies and gene editing, are all applications
where microfluidics have a role to play. In particular,
microfluidics is receiving enthusiastic response from
single-cell isolation, where there are already several
successful commercialized technologies. The other
applications mentioned above are steadily emerging,
and it is time for innovative microfluidic companies
to take the opportunity to solve the issues linked to
integration, automation, throughput increase, etc.
Indeed, most solutions used today are expensive
and low-throughput, and thus prone to human error
due to manual operations. In this report, Yole’s
analysts describe the challenges these fields face and
how microfluidic technologies, for example droplet
microfluidics, can address the bottlenecks and forge
new possibilities.
*Non-exhaustive list of companies
Single-cell isolation Cell line development Gene editing and therapeutics
Non
droplet
microfluidics
technologies
Microfluidic
technologies
droplets
Not yet in commercial production
Still at very early stage of R&D
Not yet in commercial production
Still at very early stage of R&D
Not yet in commercial production
Established
application
Emerging
application
(Yole Développement,August 2019)
Microfluidic players* landscape per revenue
(Yole Développement,August 2019)
Players* involvement in microfluidic technologies
for biotechnology applications matrix
*Non-exhaustive list of companies
*Non-exhaustive list of companies
29. AUTHORS
Sébastien Clerc works as a Technology
& Market Analyst, Microfluidics & Medical
Technologies at Yole Développement (Yole).
As part of the Life Sciences & Healthcare
division, Sébastien has authored a collection
of market and technology reports dedicated
to topics such as microfluidics, point-of-
care, MEMS for healthcare applications and
connected medical devices. In parallel, he
is daily involved in custom projects such as
strategic marketing, technology scouting and
technology evaluation to help academic and
industrial players in their innovation processes.
Thanks to his technology & market expertise,
Sébastien has spoken in more than 10 industry
conferences worldwide over the last 2 years.
Sébastien Clerc graduated from Grenoble
Institute of Technology (Grenoble INP -
Grenoble, France) with a Master’s degree in
Biomedical Technologies. He then completed
his cursus with a Master’s degree in Innovation
and Technology Management in the same
institute.
COMPANIES CITED IN THE REPORT (non exhaustive list)
3M, 10X Genomics, Abaxis (Zoetis), Abbott, Alere (Abbott), Achira Labs, Affymetrix (Thermo
Fisher Scientific), AGC, Agilent Technologies, Akatsuki Tech, Akonni Biosystems, Allevi, ALine, Alveo
Technologies, Angle plc, Applied Microarrays, Araymond Life, Arrayit, Arrayjet, Ativa Medical, Atlas
Genetics (binx health), AutoGenomics (Prescient Medicine), AxoSim, Axxicon, Axxin, Balda AG
(Stevanato Group), Base4 Innovation, BD, BGI, binx health, Biocartis, Biocept, BioFire Diagnostics
(bioMérieux), BioFluidica, Biolidics, Bionano Genomics, Bio-Rad, BioSensia (Kypha), Biosurfit,
BOE, Boehringer Ingelheim, Boehringer Ingelheim microParts, Bosch Vivalytic (Bosch Healthcare),
Bronkhorst, Caliper Life Sciences (PerkinElmer), Cambridge Consultants, CapitalBio Corporation,
Capsum, Carville, CBio, CDA, Cellenion (Scienion), Celsee Diagnostics, Centrillion Technologies,
Cepheid (Danaher), CG.TEC Injection, Chemtrix, CiDRA Precision Services (IDEX), CombiMatrix
(Invitae), Corium Corning, CorSolutions, Curetis, Cygnus Biosciences, Cytena, Cytosurge, Daktari
Diagnostics, DARPA, Debiotech, Denz Bio-Medical, Dianax, DiaSorin Molecular, DNAe and more.
As a Technology & Market Analyst,
Biotechnologies & Molecular Innovations,
Medical Technologies in the Life Sciences &
Healthcare division at Yole Développement
(Yole), Asma Siari is involved in the
development of technology & market reports
as well as the production of custom consulting
projects.
After a Master’s degree in Biotechnologies,
Diagnostic Therapeutics & Management,
Asma served as Research Assistant at the
Moores Cancer Center (San Diego, CA).
She is a coauthor in three scientific publications
published in the Molecular Cancer Research
Journal.
Asma Siari graduated with an Advanced
Master’s degree in International Strategy &
Marketing BtoB from EM Lyon Business School
(France).
Executive summary 15
Context 52
Definition – our vision of microfluidics
Microfluidics – advantages and drawbacks
Applications that use microfluidic products
Market forecasts 62
Market segmentation
Market forecasts for microfluidic products
and devices (units and value) and segment
dynamics
How value is spread across the supply chain
What we got right/wrong, and why
Material mix analysis
Market trends 87
An increasing on-chip complexity
Razor and razor-blade business model
In-house vs. outsourced production
The lure of high-volume microfluidic device
production
Attaining commercial success is not easy
Road to market: applications comparison
Reasons why companies choose to
internalize production
The barriers of in-house production
A fight to acquire value
Significant new entrants
The development of « open platform »
business models
Success of microfluidic technologies –
dream or reality?
Financial analysis of publicly-listed
companies
Microfluidic segments description 139
Clinical and veterinary testing
Point-of-care testing
Industrial, environmental, and agro-food
testing
Pharmaceutical and life science research
Micro-reaction and flow chemistry
Analytical devices
Drug delivery
Accurate dispensing
Flow control components and modules
Emerging applications
Focus : Microfluidic technologies for
biotech applications 203
Single-cell isolation and analysis
Cell line development
Gene editing and therapeutics
Supply chain and business models
Market shares and supply chain 266
Different models for different volumes
Microfluidic integrators, per material
Microfluidic integrators – 2018 market
share
Main MAs and fundraising since 2017
Microfluidic fabs: overview, geographical
location, materials, ranking
Other levels of the supply chain (design
houses, prototyping houses, materials
providers, etc.)
Analysis of recent microfluidic fabs’
acquisitions
Who’s working with who?
Technology trends 341
Materials and hybrid integration
Manufacturing processes description and
comparison
Cost analysis: cost of goods, yield,
split across the manufacturing process,
contribution of the device in the final product
selling price, gross margin analysis
Detection methods
Conclusions 374
TABLE OF CONTENTS (complete content on i-Micronews.com)
• Chinese Microfluidics Industry 2018
• Point-of-Need Testing: Application of Microfluidic
Technologies
• Liquid Biopsy: From Isolation to Downstream
Applications 2018
• Nanopore Sequencing 2019 – Patent Landscape
Analysis – by KnowMade
Find all our reports on www.i-micronews.com
RELATED REPORTS
Benefit from our Bundle Annual Subscription offers and access our analyses at the best available
price and with great advantages
MARKET TECHNOLOGY REPORT
30. ORDER FORM
Status of the Microfluidics Industry 2019
SHIPPING CONTACT
First Name:
Email:
Last Name:
Phone:
PAYMENT
BY CREDIT CARD
Visa Mastercard Amex
Name of the Card Holder:
Credit Card Number:
Card Verification
Value (3 digits except AMEX: 4 digits):
Expiration date:
BY BANK TRANSFER
BANK INFO: HSBC, 1 place de la Bourse,
F-69002 Lyon, France,
Bank code: 30056, Branch code: 00170
Account No: 0170 200 1565 87,
SWIFT or BIC code: CCFRFRPP,
IBAN: FR76 3005 6001 7001 7020 0156 587
RETURN ORDER BY
• MAIL: YOLE DÉVELOPPEMENT, Le Quartz,
75 Cours Emile Zola, 69100 Villeurbanne/Lyon - France
SALES CONTACTS
• Western US Canada - Steve Laferriere:
+ 1 310 600-8267 – laferriere@yole.fr
• Eastern US Canada - Chris Youman:
+1 919 607 9839 – chris.youman@yole.fr
• Europe RoW - Lizzie Levenez:
+ 49 15 123 544 182 – levenez@yole.fr
• Japan Rest of Asia - Takashi Onozawa:
+81-80-4371-4887 – onozawa@yole.fr
• Greater China - Mavis Wang:
+886 979 336 809 – wang@yole.fr
• Korea - Peter OK:
+82 10 4089 0233 – peter.ok@yole.fr
• Specific inquiries: +33 472 830 180 – info@yole.fr
(1)
Our Terms and Conditions of Sale are available at
www.yole.fr/Terms_and_Conditions_of_Sale.aspx
The present document is valid 24 months after its publishing date:
August 22, 2019
/
ABOUT YOLE DEVELOPPEMENT
BILL TO
Name (Mr/Ms/Dr/Pr):
Job Title:
Company:
Address:
City:
State:
Postcode/Zip:
Country*:
*VAT ID Number for EU members:
Tel:
Email:
Date:
PRODUCT ORDER - Ref YD19037
Please enter my order for above named report:
One user license*: Euro 5,990
Multi user license: Euro 6,490
- The report will be ready for delivery from September 9, 2019
- For price in dollars, please use the day’s exchange rate. All reports are
delivered electronically at payment reception. For French customers,
add 20% for VAT
I hereby accept Yole Développement’s Terms and Conditions of Sale(1)
Signature:
*One user license means only one person at the company can use the report.
Founded in 1998, Yole Développement (Yole) has grown to become a group of companies providing marketing, technology and strategy consulting, media and
corporate finance services, reverse engineering and reverse costing services and well as IP and patent analysis. With a strong focus on emerging applications using
silicon and/or micro manufacturing, the Yole group of companies has expanded to include more than 120 collaborators worldwide covering MEMS and image
sensors, Compound semiconductors, RF Electronics, Solid-state lighting, Displays, Software, Optoelectronics, Microfluidics Medical, Advanced Packaging,
Manufacturing, Power Electronics, Batteries Energy Management and Memory.
The “More than Moore” market research, technology and strategy consulting company Yole Développement, along with its partners System Plus Consulting,
PISEO, KnowMade and Blumorpho, supports industrial companies, investors and RD organizations worldwide to help them understand markets and follow
technology trends to grow their business.
CONSULTING AND ANALYSIS
• Market data research, marketing analysis
• Technology analysis
• Strategy consulting
• Reverse engineering costing
• Patent analysis
• Design and characterization of innovative optical systems
• Financial services (due diligence, MA with our partner)
More information on www.yole.fr
MEDIA EVENTS
• i-Micronews.com website, application related e-newsletter
• Communication webcast services
• Events: TechDays, forums…
More information on www.i-Micronews.com
REPORTS
• Market technology reports
• Patent investigation and patent infringement risk analysis
• Structure, process and cost analysis and teardowns
• Cost simulation tool
More information on www.i-micronews.com/reports
CONTACTS
For more information about :
• Consulting Financial Services: Jean-Christophe Eloy (eloy@yole.fr)
• Reports Monitors: David Jourdan (jourdan@yole.fr) Fayçal Khamassi
(khamassi@yole.fr)
• Marketing Communication: Camille Veyrier (veyrier@yole.fr)
• Public Relations: Sandrine Leroy (leroy@yole.fr)